101 related articles for article (PubMed ID: 19338204)
21. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma.
Siamakpour-Reihani S; Owzar K; Jiang C; Turner T; Deng Y; Bean SM; Horton JK; Berchuck A; Marks JR; Dewhirst MW; Alvarez Secord A
Gynecol Oncol; 2015 Oct; 139(1):23-9. PubMed ID: 26260910
[TBL] [Abstract][Full Text] [Related]
24. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients.
Pruneri G; Ponzoni M; Ferreri AJ; Decarli N; Tresoldi M; Raggi F; Baldessari C; Freschi M; Baldini L; Goldaniga M; Neri A; Carboni N; Bertolini F; Viale G
Br J Haematol; 2002 Sep; 118(3):817-20. PubMed ID: 12181051
[TBL] [Abstract][Full Text] [Related]
25. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M
Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178
[TBL] [Abstract][Full Text] [Related]
26. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
27. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
28. Endoglin (CD105) expression and angiogenesis status in small cell lung cancer.
Takase Y; Kai K; Masuda M; Akashi M; Tokunaga O
Pathol Res Pract; 2010 Nov; 206(11):725-30. PubMed ID: 20619547
[TBL] [Abstract][Full Text] [Related]
29. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD34 and CD105 as markers for angiogenesis in oral vascular malformations and pyogenic granulomas.
Vasconcelos MG; Alves PM; Vasconcelos RG; da Silveira ÉJD; Medeiros AMC; de Queiroz LMG
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1213-1217. PubMed ID: 21221622
[TBL] [Abstract][Full Text] [Related]
31. Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.
Miyata Y; Sakai H
Int J Urol; 2015 Sep; 22(9):806-15. PubMed ID: 26153072
[TBL] [Abstract][Full Text] [Related]
32. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
33. Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival.
Sugita Y; Takase Y; Mori D; Tokunaga O; Nakashima A; Shigemori M
J Neurooncol; 2007 May; 82(3):249-56. PubMed ID: 17102906
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic value of microvessel density and angiogenesis-related molecules in epithelial ovarian cancer].
Tan XJ; Lang JH; Lou WZ; Shen K; Xu XY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):274-8. PubMed ID: 18788631
[TBL] [Abstract][Full Text] [Related]
35. Endothelial cell activation and proliferation in ovarian tumors: two distinct steps as potential markers for antiangiogenic therapy response.
Pirtea L; Raica M; Cimpean AM
Mol Med Rep; 2012 May; 5(5):1181-4. PubMed ID: 22378599
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis in craniopharyngiomas: Microvascular density and tissue expression of the vascular endothelial growth factor (VEGF) and endostatin.
Dallago CM; Oliveira MC; Barbosa-Coutinho LM; Ferreira NP
Endocr Pathol; 2005; 16(4):355-62. PubMed ID: 16627922
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma].
Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
Przegl Lek; 2012; 69(10):726-30. PubMed ID: 23421020
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of prognostic factors for the extent of vascularity of serous ovarian cancer on the basis of CD34 antigen expression].
Blok R; Blok K; Jeleń M; Gryboś M
Ginekol Pol; 2004 Feb; 75(2):91-8. PubMed ID: 15108579
[TBL] [Abstract][Full Text] [Related]
39. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.
Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R
Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702
[TBL] [Abstract][Full Text] [Related]
40. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation].
Wang Y; Zhang XH; Guo P; Yan LN; He D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
